ULF WIINBERG
CIK 1187314 · Sr. VP&Pres. Wyeth Pharm EMEA · last filed 2026-06-02
ULF WIINBERG is a Sr. VP&Pres. Wyeth Pharm EMEA who has filed 72 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider was granted $28.0K of INKT on Jun 2, 2026. Across all open-market trades the lifetime net is −$6.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $573.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$573.0K
3
72
-$6.72M
Holdings By Company
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | INKT | Grant (A) | +2,416 | $28.0K | EDGAR |
| 2026-01-06 | INKT | Grant (A) | — | $0 | EDGAR |
| 2025-12-03 | INKT | Grant (A) | +1,263 | $14.0K | EDGAR |
| 2025-09-11 | INKT | Grant (A) | — | $0 | EDGAR |
| 2025-09-03 | INKT | Grant (A) | +1,011 | $14.0K | EDGAR |
| 2025-06-04 | INKT | Grant (A) | +1,953 | $14.0K | EDGAR |
| 2025-03-05 | INKT | Grant (A) | +1,593 | $14.0K | EDGAR |
| 2024-12-03 | INKT | Grant (A) | +20,476 | $14.9K | EDGAR |
| 2024-10-03 | AGEN | Grant (A) | — | $0 | EDGAR |
| 2024-09-05 | INKT | Grant (A) | +18,295 | $15.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.